Yusuf Ilhan, M. Korkmaz, E. Güzel, K. Mammadova, S. S. Göksu, A. Tatlı, H. Coşkun
{"title":"卵巢癌中抗- yo相关的副肿瘤小脑变性:一个罕见的病例报告","authors":"Yusuf Ilhan, M. Korkmaz, E. Güzel, K. Mammadova, S. S. Göksu, A. Tatlı, H. Coşkun","doi":"10.37047/JOS.2020-78768","DOIUrl":null,"url":null,"abstract":"rare neurological complication in cancer, characterized by the rapid development of cerebellar ataxia resulting from tumor-induced autoimmunity against cerebellar Purkinje cells. It is mostly seen in gynecological cancers, breast cancer, and small cell lung cancer.1 AntiYo antibody, also known as anti-Purkinje cell cytoplasmic antibody type-1 is highly specific and the most frequently found antibody in patients with PCD. Other antibodies associated with PCD are anti-Hu, antiTr, anti-Ri, and anti-mGluR1. However, no antibodies are identified in nearly 40% of PCD patients.2-4 PCD occurs in about 0.2% of patients with malignant tumors and is characterized by cerebellar symptoms such as ataxia, vertigo, and dysarthria.5 Here, we present a case of anti-Yo-associated PCD in an ovarian cancer patient.","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"7 1","pages":"31-33"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-Yo Associated Paraneoplastic Cerebellar Degeneration in Ovarian Cancer: A Rare Case Report\",\"authors\":\"Yusuf Ilhan, M. Korkmaz, E. Güzel, K. Mammadova, S. S. Göksu, A. Tatlı, H. Coşkun\",\"doi\":\"10.37047/JOS.2020-78768\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"rare neurological complication in cancer, characterized by the rapid development of cerebellar ataxia resulting from tumor-induced autoimmunity against cerebellar Purkinje cells. It is mostly seen in gynecological cancers, breast cancer, and small cell lung cancer.1 AntiYo antibody, also known as anti-Purkinje cell cytoplasmic antibody type-1 is highly specific and the most frequently found antibody in patients with PCD. Other antibodies associated with PCD are anti-Hu, antiTr, anti-Ri, and anti-mGluR1. However, no antibodies are identified in nearly 40% of PCD patients.2-4 PCD occurs in about 0.2% of patients with malignant tumors and is characterized by cerebellar symptoms such as ataxia, vertigo, and dysarthria.5 Here, we present a case of anti-Yo-associated PCD in an ovarian cancer patient.\",\"PeriodicalId\":31838,\"journal\":{\"name\":\"Journal of Oncological Sciences\",\"volume\":\"7 1\",\"pages\":\"31-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Oncological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37047/JOS.2020-78768\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37047/JOS.2020-78768","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Anti-Yo Associated Paraneoplastic Cerebellar Degeneration in Ovarian Cancer: A Rare Case Report
rare neurological complication in cancer, characterized by the rapid development of cerebellar ataxia resulting from tumor-induced autoimmunity against cerebellar Purkinje cells. It is mostly seen in gynecological cancers, breast cancer, and small cell lung cancer.1 AntiYo antibody, also known as anti-Purkinje cell cytoplasmic antibody type-1 is highly specific and the most frequently found antibody in patients with PCD. Other antibodies associated with PCD are anti-Hu, antiTr, anti-Ri, and anti-mGluR1. However, no antibodies are identified in nearly 40% of PCD patients.2-4 PCD occurs in about 0.2% of patients with malignant tumors and is characterized by cerebellar symptoms such as ataxia, vertigo, and dysarthria.5 Here, we present a case of anti-Yo-associated PCD in an ovarian cancer patient.